Shopping Cart
- Remove All
- Your shopping cart is currently empty
Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $35 | In Stock | |
10 mg | $55 | In Stock | |
25 mg | $113 | In Stock | |
50 mg | $178 | In Stock | |
100 mg | $289 | In Stock | |
1 mL x 10 mM (in DMSO) | $61 | In Stock |
Description | Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease. |
Targets&IC50 | mAChR:55 nM, mAChR:15 nM (Ki) |
In vitro | Metixene hydrochloride hydrate, with IC50 and Ki values of 55 nM and 15 nM, respectively, has the potential to inhibit the binding of QNB with the muscarinic receptor [1]. |
Molecular Weight | 363.95 |
Formula | C20H26ClNOS |
Cas No. | 7081-40-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 5 mg/mL (13.74c), Sonication is recommended. DMSO: 70 mg/mL (192.34 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.